RFA
BIOC

Reilly Financial Advisors’s Biocept, Inc. BIOC Stock Holding History

Reilly Financial Advisors’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Buy
+7
New +$806 ﹤0.01% 1110
2021
Q3 		– Sell
-7
Closed -$1K – 1092
2021
Q2 		$1K Buy
7
+4
+133% +$541 ﹤0.01% 982
2021
Q1 		$1K Hold
3
– – ﹤0.01% 1004
2020
Q4 		$0 Buy
+3
New +$428 ﹤0.01% 941

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Reilly Financial Advisors's BIOC Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Biocept, Inc. (BIOC) in Q4 2021: 7 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: Reilly Financial Advisors previously reported a position in BIOC as recently as Q2 2021.

Reilly Financial Advisors first reported a position in BIOC in Q4 2020 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold BIOC as of Q4 2021.

  • Reilly Financial Advisors held 7 shares of Biocept, Inc. worth $1K as of Q4 2021.
  • Biocept, Inc. was a new Reilly Financial Advisors position in Q4 2021.
  • Biocept, Inc. made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1110 holding.
  • Reilly Financial Advisors first reported a position in Biocept, Inc. in Q4 2020 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.